Sol-Gel Technologies Ltd.
NASDAQ: SLGL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Moshe Arkin
- Employees
- 34
- Headquarters
- Ness Ziona, Israel
- IPO year
- 2018
- Market cap
- $206.2M
- Website
- https://www.sol-gel.com
Loading SLGL…
Loading profile data…Frequently asked questions about SLGL
What does Sol-Gel Technologies Ltd. (SLGL) do?
Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel...
Where does SLGL trade?
Sol-Gel Technologies Ltd. (SLGL) trades on the NASDAQ Global Market.
What sector is SLGL in?
Sol-Gel Technologies Ltd. (SLGL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sol-Gel Technologies Ltd.?
Moshe Arkin is the chief executive officer of Sol-Gel Technologies Ltd. (SLGL).
Where is Sol-Gel Technologies Ltd. headquartered?
Sol-Gel Technologies Ltd. is headquartered in Israel.
Does SLGL pay a dividend?
Sol-Gel Technologies Ltd. (SLGL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SLGL go public?
Sol-Gel Technologies Ltd. (SLGL) completed its initial public offering in 2018.